:

Homeland Security

SRI International Gets $9.5M DTRA Award for Bio-Warfare Drugs

DDN

Wednesday, October 17th, 2007

SHARE:

SRI International received a $9.5 million contract from the Defense Threat Reduction Agency (DTRA) to lead a drug discovery and development program to identify approved drugs that could also be effective against biological threats. The goal of the program is to repurpose drugs that are currently approved and marketed but have not been previously evaluated against diseases caused by biological weapons. SRI's partners in the program include the U.S. Army Institute for Infectious Diseases, Southwest Foundation for Biomedical Research, The…

Congress

HASC Bill Would Allow Air Force To Buy More Than 267 F-15EXs

The House Armed Services Committee’s (HASC) fiscal 2027 defense authorization bill would allow the Air Force to buy more than 267 F-15EX fighters by Boeing [BA] and would extend the […]

Budget

Defense Bill Tries To Block Foreign Shipbuilding, Adds $1 Billion For Second DDG

The final version of the House Armed Services Committee’s (HASC) fiscal year 2027 defense authorization bill included two amendments pushed by Rep. Jared Golden (D-Maine) that restrict procuring Navy warships […]

Congress

Replacement Munitions May Not Be One-for-One; May Include New Weapons Chemistries, Wittman Says

As the Pentagon looks to refill inventories of weapons used in Iran and elsewhere, replacements may not be one for one but instead mark a new portfolio mix, according to […]

Congress

HASC Approves $1.15 Trillion FY ‘27 NDAA With ‘Right To Repair’ Reform

The House Armed Services Committee (HASC) has approved its $1.15 trillion version of the fiscal year 2027 National Defense Authorization Act (NDAA), with the panel moving to adopt a bipartisan […]